John C. McKew
2021
In 2021, John C. McKew earned a total compensation of $1.4M as President and Chief Scientific Officer at NewLink Genetics, a 15% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $262,500 |
|---|---|
| Option Awards | $420,881 |
| Salary | $490,308 |
| Stock Awards | $170,703 |
| Other | $52,176 |
| Total | $1,396,568 |
McKew received $490.3K in salary, accounting for 35% of the total pay in 2021.
McKew also received $262.5K in non-equity incentive plan, $420.9K in option awards, $170.7K in stock awards and $52.2K in other compensation.
Rankings
In 2021, John C. McKew's compensation ranked 7,559th out of 12,406 executives tracked by ExecPay. In other words, McKew earned more than 39.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,559 out of 12,406 | 39th |
Division Manufacturing | 3,326 out of 5,494 | 40th |
Major group Chemicals And Allied Products | 1,474 out of 2,369 | 38th |
Industry group Drugs | 1,312 out of 2,090 | 37th |
Industry Pharmaceutical Preparations | 967 out of 1,537 | 37th |
Source: SEC filing on March 23, 2022.
McKew's colleagues
We found two more compensation records of executives who worked with John C. McKew at NewLink Genetics in 2021.
News
NewLink Genetics CEO Richard Hawkins' 2023 pay falls 25% to $953K
April 12, 2024
NewLink Genetics CEO Richard Hawkins' 2022 pay slips 6% to $1.3M
March 31, 2023
NewLink Genetics CSO John McKew's 2021 pay rises 15% to $1.4M
March 23, 2022
NewLink Genetics CEO Richard Hawkins' 2020 pay jumps 200% to $2.2M
April 6, 2021
NewLink Genetics Former Chief Executive & Scientific Officer Charles Link's 2019 pay falls 38% to $1.7M
June 23, 2020